Goal hub

Weight Loss Plateau Breakthrough

Tesamorelin VAT label versus off-label secretagogue folklore. Visceral fat that “refuses to burn” is not a research-chem indication.

Full stacking map, tiers, and monitoring notes live on the protocol page — this hub only lists the compounds already named for this goal.

Open full protocol All goals

Compounds on this goal

Tesamorelin

gh_secretagogue

FDA-approved as Egrifta for HIV-associated lipodystrophy VAT. That file is not a general-population cut protocol.

Open peptide leaf →

AOD-9604

fat_loss

The specific fragment of the Human Growth Hormone molecule that is responsible for fat burning, without the insulin-resistance side effects of full HGH.

Open peptide leaf →

MOTS-c

mitochondrial

Addresses the actual root cause of the plateau: mitochondrial inefficiency and metabolic downregulation from long-term dieting.

Open peptide leaf →